- Current report filing (8-K)
13 August 2009 - 6:35PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
August 7, 2009
Date of Report (Date of earliest event reported)
MOLEX INCORPORATED
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
0-7491
|
|
36-2369491
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
2222 Wellington Court, Lisle, Illinois 60532
(Address and zip code of principal executive offices)
(630) 969-4550
(Registrants telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
|
|
|
Item 5.02
|
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
|
On August 7, 2009, the Board of Directors (the Board) of Molex Incorporated (Molex), upon the
recommendation of the Corporate Governance & Nominating Committee, increased the size of the Board
to 13 members and elected Dr. Anirudh Dhebar, a professor of
marketing at Babson College since 1997, as a Class II
member of the Board. Dr. Dhebar, as a member of Class II, will stand for election at the 2010
Annual Meeting of Shareholders. Dr. Dhebar has not yet been assigned to any Board committees.
There is no arrangement or understanding with any person pursuant to which Dr. Dhebar was selected
as a director, and he is not a party to any transaction requiring disclosure under Item 404(a) of
Regulation S-K.
Dr. Dhebars compensation for his service as a non-employee director will be consistent with that
of Molexs other non-employee directors as described in Exhibit 99.1 hereto. The nonemployee
director compensation program is described in further detail in the Companys proxy statement for
its 2008 Annual Meeting filed with the Securities and Exchange Commission on September 12, 2008.
|
|
|
Item 9.01
|
|
Financial Statements and Exhibits
|
(d) Exhibits.
Exhibit 99.1 Summary of Non-Employee Director Compensation
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
MOLEX INCORPORATED
|
|
Date: August 13, 2009
|
By:
|
/s/ MARK R. PACIONI
|
|
|
|
Mark R. Pacioni
|
|
|
|
Corporate Secretary
|
|
|
EXHIBIT INDEX
|
|
|
Exhibit No.
|
|
Description
|
|
|
|
Exhibit 99.1
|
|
Summary of Non-Employee Director Compensation
|
Molex Incorporated (MM) (NASDAQ:MOLX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Molex Incorporated (MM) (NASDAQ:MOLX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024